News > MSN rolls out generic version of breast cancer drug

MSN rolls out generic version of breast cancer drug

MSN Group has launched a generic version of the breast cancer drug Palbociclib in tablet form under the brand name Palborest. While there are a few other firms that have launched Palbociclib in capsule dosage form, MSN said it has taken a lead in developing the drug in tablet form in line with the innovator Palbace tablets. The company said its pricing of the tablets, available in 75mg, 100mg and 125mg strengths, is more affordable and bioequivalent to innovator tablets.